Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1541 of 6351
-
Can targeted exercises boost relief for cubital tunnel syndrome?
Symptom relief CompletedCubital tunnel syndrome occurs when the ulnar nerve is compressed or irritated near the elbow. It can cause elbow or forearm pain, numbness or tingling in the ring and little fingers, hand weakness, and difficulty performing daily activities. This randomized clinical trial will …
Sponsor: Hamna Sarfraz • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New asthma drug brenipatide enters Mid-Stage trial
Disease control Recruiting nowThe purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with moderate-to-severe asthma. Study participation will last approximately 65 weeks, including screening, treatment, and follow-up period…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New radioactive drug targets FAP-Positive tumors in early trial
Disease control Recruiting nowThis is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread. Participants must have cancer with high levels of a protein called fibroblast activation protein (FAP). The purpose of this study is to evaluate safety, side effects, and eff…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Fresh produce prescription aims to cut hospital visits for heart failure patients
Disease control Recruiting nowThe purpose of this parallel pragmatic randomized controlled trial (RCT) is to evaluate the impact of Eat Well (an evidence-based 'Food is Medicine' produce prescription program) with varying levels of behavioral support on health outcomes and care utilization patterns of Duke He…
Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New pill aims to tame chaotic heartbeats in atrial fibrillation
Disease control Recruiting nowA clinical Randomized Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Phase 2 • Sponsor: Acesion Pharma • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Balloon vs stent: which is better for tricky heart blockages?
Disease control Recruiting nowA prospective, multi-center, open-label, randomized controlled, superiority trial. The aim of the study is to compare clinical outcomes between upfront 2-stenting strategy versus upfront drug-coated balloon (DCB)-based hybrid strategy in patients with complex coronary bifurcation…
Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
At-Home HPV test could boost screening in underserved women
Diagnosis Recruiting nowPhase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients. Phase II: Evaluate the feasibility and acceptability of the CHW4CervicalHealth: Use of a self-collection kit to improve cervical health screening interv…
Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
AI coach aims to cut hospital stays for millions with chronic disease
Disease control Recruiting nowThe primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health Artificial Intelligence (AI) Chatbot, Copilot, Large Language Model (LLM) and vital sign monitoring device in reducing CKM disease…
Sponsor: Aventyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can brain scans unlock the secret to hearing in crowded rooms?
Knowledge-focused Recruiting nowUnderstanding speech in restaurants and other noisy environments is the most common complaint from the more than 60 million Americans with hearing impairment. Succeeding in such environments requires a listener to first segregate sound sources and then selectively attend to the s…
Sponsor: University of South Florida • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
AI eye test could catch glaucoma early in underserved communities
Diagnosis Recruiting nowThe goal of this clinical trial is to learn if implementation of an eye screening program at Federally Qualified Health Center (FQHC) clinics provides results that participants may have glaucoma, and/or other eye conditions (diabetic retinopathy, cataract, visual acuity impairmen…
Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Recruiting nowThis is a first-in-human, Phase I, open-label, multi-center, dose-escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of JMKX005425 in subjects with microsatellite instability-high (MSI) and/or mismatch repair defic…
Phase 1 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New hope for kids with AML: gentler chemo combos under trial
Disease control Recruiting nowThis research study investigates the tolerability of substituting two cycles of chemotherapy into the standard pediatric acute myeloid leukemia (AML) chemotherapy treatment regimen for patients with newly diagnosed AML at intermediate-risk (IR) and high-risk (HR) of relapse. The …
Early phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a common probiotic soothe IBS? new trial seeks answers
Symptom relief Recruiting nowThis is a double-blind, randomized (group assignment by chance), placebo-controlled, multicenter trial which will be conducted over a 13.5-months period The main objective of the research is to demonstrate the efficacy of Saccharomyces boulardii CNCM I-745 on global IBS symptoms,…
Phase 3 • Sponsor: Biocodex • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New antibiotic treatment aims to stop infections in breast cancer reconstruction
Prevention Recruiting nowThe researchers are doing this study to find out whether Stimulan Rapid Cure works to reduce the risk of infections in people getting tissue expanders placed during mastectomy. The researchers will also study whether Stimulan Rapid Cure affects the risk of seroma, a possible comp…
Phase 4 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jul 12, 2026 00:00 UTC
-
New surgical wrap could slash deadly leak risk in rectal cancer patients
Disease control Recruiting nowThe goal of this clinical trial is to learn whether using a reinforcing material called SIS (small intestinal submucosa) during bowel connection after rectal cancer surgery can help prevent anastomotic leakage-a serious complication where the connection between two parts of the i…
Phase 4 • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New Needle-Sized device could replace surgery for dialysis access
Disease control Recruiting nowThis study will evaluate the Velocity Percutaneous Arteriovenous Fistula (pAVF) System, a new minimally invasive method for creating dialysis access. People with kidney failure often require dialysis, which depends on having a reliable arteriovenous fistula (AVF). Traditionally, …
Sponsor: Venova Medical • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New catheter treatment for irregular heartbeat under Long-Term review
Disease control Recruiting nowThe purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for kids with Tough-to-Treat neuroblastoma: experimental drug combo enters human testing
Disease control Recruiting nowBackground: Neuroblastoma is a type of cancer that causes tumors in nerves. It affects mainly infants and toddlers, and it causes about 15 percent of cancer-related deaths in children. Objective: To test a new drug (rhIL-15), combined with 3 standard cancer drugs, in people wi…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Before surgery, speech lessons for cleft palate babies?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if teaching speech skills to infants with cleft palates, prior to palate repair, will help them to develop speech and language skills. It will also learn about whether the skills are linked to fewer speech sound difficulties when they s…
Sponsor: Old Dominion University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New vaccine aims to supercharge COVID-19 immunity
Vaccine Recruiting nowThe goal of this clinical trial is to test two investigational COVID-19 booster vaccines, called CoTend-s3BXBB and CoTend-BXBB, in healthy volunteers ages 40-64. The CoTend-s3BXBB vaccine includes a component called "s3", which was designed to improve the body's response to the v…
Phase 1/2 • Sponsor: Kara Chew • Aim: Vaccine
Last updated Aug 20, 2026 00:00 UTC